Study Finds the Economic Benefits of Preventive Chemotherapy in NTDs to be Potentially huge among the Poor

COUNTDOWN's Lead Health Economist - Prof. Louis Niessen who co-authored the paper in the PLOS NTDs journal is quoted saying: “This study links poverty and neglected diseases, putting NTDs higher on the international agenda on the Sustainable Development Goals. Despite large uncertainty, these benefits far exceed the investment required by governments and their development partners within all reasonable scenarios. Given the concentration of the NTDs among the poorest households, these investments represent good value for money in efforts to share the world’s prosperity and reduce inequity.” 

To read this paper, follow this link...

Prof. Louis Niessen